A number of reports (Asano et al. 2009; Shao et al. 2018) suggest that biallelic mutations in SLC26A3 may confer increased risk for the development inflammatory bowel disease (IBD) later in life. Here, SLC26A3 is linked to inflammatory bowel disease.